Everlywell, Jona Team Up to Expand Access to Gut Microbiome Test
Through a new partnership, consumers nationwide can access Jona’s gut microbiome test on Everlywell’s platform.
FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder
Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy developed to treat leukocyte-adhesion deficiency type 1, an inherited immunodeficiency that can become fatal to infants and young children. Kresladi is the first gene therapy for this ultra-rare disease and the first commercial product for Rocket.
How Are Health Systems Assessing ROI for AI Tools?
Michael Meucci, CEO of health data platform Arcadia, thinks health systems are changing their thinking about ROI when it comes to AI projects. As providers face tighter budgets, he said they’re broadening how they measure AI’s ROI, including benefits like reducing clinician burnout.
Scaling Autonomous AI in Healthcare Without Compromising Clinical Trust
AI in healthcare will not fail because the models are weak. It will stall when leaders hesitate to redesign how decisions are made, measured and governed.
The Cost Blind Spot: Why Non-Clinical Spend Is Healthcare’s Untapped Opportunity
Providers that embrace benchmarks from outside of healthcare and move toward improved non-clinical spend management will unlock the resilience, innovation, and possibilities needed to stay strong in the years ahead.